Jiao Y, An M, Zhang N, Zhang H, Zheng C, Chen L
Virol J. 2024; 21(1):306.
PMID: 39593171
PMC: 11590514.
DOI: 10.1186/s12985-024-02563-z.
Geng H, Liu B, Liu Y, Chen S, Shi H, Fan W
AIDS Res Hum Retroviruses. 2024; 40(7):449-453.
PMID: 38407970
PMC: 11295790.
DOI: 10.1089/AID.2023.0119.
Romero E, Feder A
Mol Biol Evol. 2024; 41(1).
PMID: 38197289
PMC: 10777272.
DOI: 10.1093/molbev/msad260.
Bacque J, Delgado E, Gil H, Ibarra S, Benito S, Garcia-Arata I
Front Microbiol. 2023; 14:1301374.
PMID: 38125564
PMC: 10731470.
DOI: 10.3389/fmicb.2023.1301374.
Romero E, Feder A
bioRxiv. 2023; .
PMID: 37873119
PMC: 10592651.
DOI: 10.1101/2023.05.05.539643.
HIV-1-Specific Immunodominant T-Cell Responses Drive the Dynamics of HIV-1 Recombination Following Superinfection.
Zhang H, Cao S, Gao Y, Sun X, Jiang F, Zhao B
Front Immunol. 2022; 12:820628.
PMID: 35095925
PMC: 8794799.
DOI: 10.3389/fimmu.2021.820628.
Identification of CRF89_BF, a new member of an HIV-1 circulating BF intersubtype recombinant form family widely spread in South America.
Delgado E, Fernandez-Garcia A, Perez-Losada M, Moreno-Lorenzo M, Fernandez-Miranda I, Benito S
Sci Rep. 2021; 11(1):11442.
PMID: 34075073
PMC: 8169922.
DOI: 10.1038/s41598-021-90023-x.
The HIV-1 latent reservoir is largely sensitive to circulating T cells.
Warren J, Zhou S, Xu Y, Moeser M, MacMillan D, Council O
Elife. 2020; 9.
PMID: 33021198
PMC: 7593086.
DOI: 10.7554/eLife.57246.
Template-switching mechanism of a group II intron-encoded reverse transcriptase and its implications for biological function and RNA-Seq.
Lentzsch A, Yao J, Russell R, Lambowitz A
J Biol Chem. 2019; 294(51):19764-19784.
PMID: 31712313
PMC: 6926447.
DOI: 10.1074/jbc.RA119.011337.
Impacts of HIV Cure Interventions on Viral Reservoirs in Tissues.
Denton P, Sogaard O, Tolstrup M
Front Microbiol. 2019; 10:1956.
PMID: 31497010
PMC: 6712158.
DOI: 10.3389/fmicb.2019.01956.
A case report of HIV-1 superinfection in an HIV controller leading to loss of viremia control: a retrospective of 10 years of follow-up.
Caetano D, Cortes F, Bello G, de Azevedo S, Hoagland B, Villela L
BMC Infect Dis. 2019; 19(1):588.
PMID: 31277590
PMC: 6612226.
DOI: 10.1186/s12879-019-4229-3.
Near-Full-Length Genetic Characterization of a Novel HIV-1 Unique Recombinant with Similarities to A1, CRF01_AE, and CRFO2_AG Viruses in Yaoundé, Cameroon.
Acharya A, Fonsah J, Mbanya D, Njamnshi A, Kanmogne G
AIDS Res Hum Retroviruses. 2019; 35(8):762-768.
PMID: 30860392
PMC: 6688114.
DOI: 10.1089/AID.2019.0042.
Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption.
Vibholm L, Lorenzi J, Pai J, Cohen Y, Oliveira T, Barton J
J Virol. 2019; 93(8).
PMID: 30700598
PMC: 6450127.
DOI: 10.1128/JVI.01920-18.
Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117.
Cohen Y, Lorenzi J, Krassnig L, Barton J, Burke L, Pai J
J Exp Med. 2018; 215(9):2311-2324.
PMID: 30072495
PMC: 6122972.
DOI: 10.1084/jem.20180936.
Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection.
Song H, Giorgi E, Ganusov V, Cai F, Athreya G, Yoon H
Nat Commun. 2018; 9(1):1928.
PMID: 29765018
PMC: 5954121.
DOI: 10.1038/s41467-018-04217-5.
Immunological and virological characteristics of human immunodeficiency virus type 1 superinfection: implications in vaccine design.
Gao Y, Tian W, Han X, Gao F
Front Med. 2017; 11(4):480-489.
PMID: 29170914
PMC: 5783723.
DOI: 10.1007/s11684-017-0594-8.
Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.
Kijak G, Sanders-Buell E, Chenine A, Eller M, Goonetilleke N, Thomas R
PLoS Pathog. 2017; 13(7):e1006510.
PMID: 28759651
PMC: 5552316.
DOI: 10.1371/journal.ppat.1006510.
Transmission of Multiple HIV-1 Subtype C Transmitted/founder Viruses into the Same Recipients Was not Determined by Modest Phenotypic Differences.
Song H, Hora B, Giorgi E, Kumar A, Cai F, Bhattacharya T
Sci Rep. 2016; 6:38130.
PMID: 27909304
PMC: 5133561.
DOI: 10.1038/srep38130.
Latency reversal and viral clearance to cure HIV-1.
Margolis D, Garcia J, Hazuda D, Haynes B
Science. 2016; 353(6297):aaf6517.
PMID: 27463679
PMC: 5021637.
DOI: 10.1126/science.aaf6517.
Relative rate and location of intra-host HIV evolution to evade cellular immunity are predictable.
Barton J, Goonetilleke N, Butler T, Walker B, McMichael A, Chakraborty A
Nat Commun. 2016; 7:11660.
PMID: 27212475
PMC: 4879252.
DOI: 10.1038/ncomms11660.